Vitro Biopharma, Inc.
CIK: 0000793171
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation NV
Business Address 3200 CHERRY CREEK DRIVE SOUTH, DENVER, CO, 80209
Mailing Address 3200 CHERRY CREEK DRIVE SOUTH, DENVER, CO, 80209
Phone 8558487627
Fiscal Year End 1031
EIN 841012042
Financial Overview
FY2025 FY
$1.86M
Revenue
$5.22M
Total Assets
$21.26M
Total Liabilities
-$1.09M
Stockholders' Equity
$-2.44
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | February 13, 2026 | View on SEC |
| 10-Q Quarterly financial report | September 12, 2025 | View on SEC |
| 10-Q Quarterly financial report | June 20, 2025 | View on SEC |
Annual Reports
10-K February 13, 2026
- Advancing proprietary AlloRx Stem Cells through Phase I/II clinical trials with key data readouts anticipated in late 2024 and early 2025.
- Strong revenue growth driven by the InfiniVive aesthetic product line's expanding market acceptance and distribution.
Related Companies
Companies in the same industry (SIC: 2836)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
PALISADE BIO, INC.
PALI Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.